Home›Stock Screener›Sandu Pharmaceuticals

Sandu Pharmaceuticals Share Price Today | Stock Price & Sandu Pharmaceuticals Share Screener

SANDUPHQ Pharmaceuticals
Live Share Price BSE
₹37.27
▲ 0.74 (2.03%)
2026-10-05 00:00:00

As of October 5, 2026, the live Sandu Pharmaceuticals share price (BSE: SANDUPHQ) is ₹37.27, up 2.03% from the previous close, with shares trading between ₹35.33 and ₹38.00 in today's trading session, and a 52-week range of ₹30.52–₹46.12. Check SANDUPHQ 52-week performance for the annual price range and momentum. Use the Sandu Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sandu Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Sandu Pharmaceuticals Market Cap ₹35.31 Cr.
SANDUPHQ P/E Ratio (TTM) 22.48
Sandu Pharmaceuticals P/B Ratio 1.05
EPS (TTM) ₹1.60
Dividend Yield -
Debt to Equity -
SANDUPHQ 52 Week High ₹46.12
Sandu Pharmaceuticals 52 Week Low ₹30.52
Operating Margin 3.00%
Profit Margin -
SANDUPHQ Revenue (TTM) ₹14.00
EBITDA ₹1.00
Net Income -
Total Assets ₹56.00
Total Equity ₹42.00

Sandu Pharmaceuticals Share Price Chart

Track the current stock price of Sandu Pharmaceuticals with an interactive chart. Analyse SANDUPHQ share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sandu Pharmaceuticals stock quote in one place.

The quote of ₹37.27 sits between the 52-week low of ₹30.52 and the 52-week high of ₹46.12, and the latest session moved 2.03% from the previous close.

Sandu Pharmaceuticals Company Profile - Fundamental Screener

Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANDUPHQ shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE751D01014.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE751D01014

Sandu Pharmaceuticals Balance Sheet Screener

Screen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹56, up from ₹52 in 2024.

Latest statistics put total assets at ₹56 and shareholder funds at ₹42.

Item 2025 2024 2023

Assets

Total Assets 56 52 54
Current Assets 26 22 26
Fixed Assets 18 18 17

Liabilities

Total Liabilities 0 0 0
Current Liabilities 2 1 1
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 42 41 39
Share Capital 10 10 10
Reserves & Surplus 32 31 30

Sandu Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen Sandu Pharmaceuticals income statement and profit fundamentals. Analyze SANDUPHQ quarterly results. Sandu Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹14 and net profit was ₹0, equal to earnings per unit of ₹0.34, at an operating margin of 3%.

In that period expenses were ₹14, interest cost ₹0 and tax ₹0. The next period listed, 2024-Dec, shows revenue of ₹18 and net profit of ₹1.

Item 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun 2022-Mar 2021-Sept 2021-Jun

Revenue and Expenses

Revenue 14 18 18 17 16 18 17 18 15 17 17 16 12 18 17
Expenses 14 17 17 17 15 17 16 17 15 16 16 16 11 17 17

Operating Costs and Margins

EBITDA 1 1 1 0 1 1 1 0 1 1 1 0 1 1 1
Operating Profit % 3.00% 5.00% 5.00% 2.00% 4.00% 3.00% 5.00% 2.00% 3.00% 5.00% 5.00% 2.00% 5.00% 5.00% 4.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 1 1 0 1 0 1 0 0 1 1 0 0 1 1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 1 1 0 1 0 1 0 0 1 1 0 0 0 0
EPS 0.34 0.57 1.95 0.17 0.62 0.21 0.57 0.11 0.26 0.51 0.64 0.19 0.34 0.57 0.53

Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹1.

Over the same period, investing activities provided ₹0 and financing activities used ₹1.

Item 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 1 1 0
Investing Activities 0 -1 1

Financing and Net Cash

Financing Activities -1 -1 1
Net Cash Flow 0 -1 1

Sandu Pharmaceuticals Shareholding Pattern Screener

See Sandu Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Sandu Pharmaceuticals promoter holding and ownership changes for SANDUPHQ on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 37.79%, foreign institutions 0.00%, domestic institutions 0.01% and the public 37.02%, spread across 10,268 shareholders.

The shareholder count was 10,268 in 2026-Jun, compared with 10,298 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 37.79% 37.79% 42.90% 42.90% 42.90% 37.79% 42.90% 42.90%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 37.02% 36.98% 35.90% 36.57% 36.77% 37.01% 44.16% 44.25%
Other Holding 25.19% 25.23% 21.20% 20.53% 20.32% 25.19% 12.93% 12.84%
Shareholder Count 10,268 10,298 10,287 10,226 10,284 10,284 10,001 10,012

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sandu Pharmaceuticals. Sandu Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.80 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.80 and ₹0.80 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.80 2.62%
2024-March ₹0.80 1.63%
2023-March ₹0.00 0.00%
2022-March ₹0.75 1.43%
2021-March ₹0.50 0.71%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sandu Pharmaceuticals Stock Index Membership - Nifty & Sensex

See which indices include Sandu Pharmaceuticals stock. Check SANDUPHQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sandu Pharmaceuticals is not part of any tracked indices.
Only major market indices are tracked in our system.

Sandu Pharmaceuticals Market Events Screener - Corporate Actions

Get Sandu Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sandu Pharmaceuticals stock events that may affect SANDUPHQ share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 11, 2026, with a record date of September 11, 2026.

It is followed by Dividend dated September 4, 2026 and Quarterly Result Announcement dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-11 2026-09-11 Annual General Meeting NA -4.87%
2026-09-04 2026-09-04 Dividend ₹ 1.00 /share -9.00%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 1.95%
2026-05-05 2026-05-05 Quarterly Result Announcement NA -1.85%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 2.05%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.51%
2025-09-30 2025-09-30 Annual General Meeting NA -3.84%
2025-09-18 2025-09-18 Dividend ₹ 0.80 /share -12.97%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.76%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 4.41%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -3.54%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 2.33%
2024-09-30 2024-09-30 Annual General Meeting NA 3.42%
2024-09-19 2024-09-20 Dividend ₹ 0.80 /share 4.55%
2023-09-18 2023-09-19 Dividend ₹ 0.75 /share 41.02%

Sandu Pharmaceuticals Competitors Screener - Peer Stocks Comparison

Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Sandu Pharmaceuticals Company Announcements - News & Reports Screener

Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated September 22, 2026 and September 12, 2026.

Date Update Actions
2026-10-02 Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details -
2026-09-22 Closure of Trading Window -
2026-09-12 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-09-12 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-09-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-11 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-19 Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTA -
2026-08-19 Reg. 34 (1) Annual Report. -
2026-08-19 Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing (VC)/ Other Audio Visual Means (QAVM) -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Approval Of Material Related Party Transactions Subject To Approval Of Shareholders -
2026-08-11 Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026 -
2026-08-11 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-11 Intimation About The Date Of The Annual General Meeting -
2026-08-11 Intimation About The Record Date -
2026-08-11 Intimation About Book Closure For AGM -
2026-08-11 Outcome And Results Of The Board Meeting Dated 11.08.2026 Was Submitted On Time But Inadvertently No Digital Signature Was Affixed On The Covering Letter Further There Is No Change In The Contents Of The Outcome -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹37.27, within a 52-week range of ₹30.52 to ₹46.12. The P/E ratio is 22.48 and the P/B ratio is 1.05, with earnings per unit of ₹1.60. Market capitalisation stands at ₹35.31 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 15 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.